nishide syunji 西出峻治

… Alternative Names

Researcher Number	10803132
Affiliation (Current)	2021: 大阪市立大学, 大学院医学研究科, 研究員
Affiliation (based on the past Project Information) *help	2019: 大阪市立大学, 大学院医学研究科, 後期臨床研究医 2017 – 2018: 大阪市立大学, 大学院医学研究科, 医員
Review Section/Research Field	Principal Investigator Urology / Basic Section 56030:Urology-related
Keywords	Principal Investigator 腫瘍免疫 / がん微小環境 / マクロファージ / PHD阻害薬 / 貪食能 / 低酸素誘導因子 / PHD阻害剤 / 癌 / 腫瘍血管 / 腫瘍関連マクロファージ / 腫瘍環境

がん微小環境改善薬による腫瘍免疫活性化機序の解明Principal InvestigatorOngoing
- Principal Investigator
  
  西出峻治
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Osaka City University
Developing of tumor microenvironment improvement therapy to induce anti-tumor immunityPrincipal Investigator
- Principal Investigator
  
  Nishide Shunji
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Urology
- Research Institution
  Osaka City University

All 2020 2019

All Journal Article Presentation

[Journal Article] Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice.2020
- Author(s)
  Nishide Shunji、Uchida Junji、Matsunaga Shinji、Tokudome Kentaro、Yamaguchi Takehiro、Kabei Kazuya、Moriya Taiki、Miura Katsuyuki、Nakatani Tatsuya、Tomita Shuhei
- Journal Title
  
  Journal of Pharmacological Sciences
  
  Volume: 143 Pages: 122-126
- DOI
  10.1016/j.jphs.2020.02.010
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K14598, KAKENHI-PROJECT-19K16651, KAKENHI-PROJECT-19K18594, KAKENHI-PROJECT-17K08958
[Journal Article] Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model.2019
- Author(s)
  Nishide Shunji、Matsunaga Shinji、Shiota Masayuki、Yamaguchi Takehiro、Kitajima Shojiro、Maekawa Yoichi、Takeda Norihiko、Tomura Michio、Uchida Junji、Miura Katsuyuki、Nakatani Tatsuya、Tomita Shuhei
- Journal Title
  
  iScience
  
  Volume: 19 Pages: 940-954
- DOI
  10.1016/j.isci.2019.08.033
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16651, KAKENHI-PROJECT-19K18594, KAKENHI-PROJECT-17K08958
[Presentation] 新規経口腎性貧血治療薬による腫瘍への影響2020
- Author(s)
  西出峻治、内田潤次、島田久生、香束昌宏、壁井和也、岩井友明、熊田憲彦、長沼俊秀、武本佳昭、仲谷達也
- Organizer
  第53回日本臨床腎移植学会
- Data Source
  KAKENHI-PROJECT-19K18594
[Presentation] Alteration the phenotype of tumor-infiltrating macrophages via the PHD-HIF axis inhibits tumor growth in mice2020
- Author(s)
  Shunji Nishide, Shinji Matsunaga, Takehiro Yamaguchi, Norihiko Takeda, Junji Uchida, Katsuyuki Miura, Tatsuya Nakatani and Shuhei Tomita
- Organizer
  Hypoxia; KEYSTONE SYMPOSIA
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K18594
[Presentation] Explore the effect of PHD inhibitor on innate immune systems in tumor mouse model2019
- Author(s)
  Shunji Nishide
- Organizer
  薬理学会総会
- Data Source
  KAKENHI-PROJECT-17H07024
[Presentation] 腎性貧血治療薬Roxadustatの自然免疫系への影響2019
- Author(s)
  西出峻治
- Organizer
  臨床腎移植学会
- Data Source
  KAKENHI-PROJECT-17H07024
[Presentation] 腎性貧血治療薬Roxadustatを用いた新たな腫瘍免疫療法の開拓2019
- Author(s)
  西出峻治、内田潤次、松永慎司、島田久生、香束昌宏、壁井和也、岩井友明、長沼俊秀、武本佳昭、冨田修平、仲谷達也
- Organizer
  第69回日本泌尿器科学会中部総会
- Data Source
  KAKENHI-PROJECT-19K18594
[Presentation] 新規の経口腎性貧血治療薬Roxadustatによる免疫系への影響2019
- Author(s)
  西出峻治、内田潤次、松永慎司、島田久生、香束昌宏、壁井和也、岩井友明、長沼俊秀、武本佳昭、冨田修平、仲谷達也
- Organizer
  第55回日本移植学会総会
- Data Source
  KAKENHI-PROJECT-19K18594

1. MIURA Katsuyuki

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. MORIYA Taiki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 山口雄大

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
4. 富田修平

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

nishide syunji 西出 峻治

Nishide Shunji 西出 峻治

Research Projects

Research Products

Co-Researchers

がん微小環境改善薬による腫瘍免疫活性化機序の解明Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Developing of tumor microenvironment improvement therapy to induce anti-tumor immunityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Prolyl-hydroxylase inhibitors reconstitute tumor blood vessels in mice.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model.2019

Author(s)

Journal Title

DOI

Data Source

[Presentation] 新規経口腎性貧血治療薬による 腫瘍への影響2020

Author(s)

Organizer

Data Source

[Presentation] Alteration the phenotype of tumor-infiltrating macrophages via the PHD-HIF axis inhibits tumor growth in mice2020

Author(s)

Organizer

Data Source

[Presentation] Explore the effect of PHD inhibitor on innate immune systems in tumor mouse model2019

Author(s)

Organizer

Data Source

[Presentation] 腎性貧血治療薬Roxadustatの自然免疫系への影響2019

Author(s)

Organizer

Data Source

[Presentation] 腎性貧血治療薬Roxadustatを用いた 新たな腫瘍免疫療法の開拓2019

Author(s)

Organizer

Data Source

[Presentation] 新規の経口腎性貧血治療薬Roxadustatによる 免疫系への影響2019

Author(s)

Organizer

Data Source

nishide syunji 西出峻治

Nishide Shunji 西出峻治

[Presentation] 新規経口腎性貧血治療薬による腫瘍への影響2020

[Presentation] 腎性貧血治療薬Roxadustatを用いた新たな腫瘍免疫療法の開拓2019

[Presentation] 新規の経口腎性貧血治療薬Roxadustatによる免疫系への影響2019